PaxMedica

Tarrytown, United States

PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.

$7.0M raised

Nov 2023

Post-IPO Equity

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has PaxMedica raised?

PaxMedica has raised $7.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in November 2023.

Who are PaxMedica's investors?

PaxMedica's investors include The Lind Partners, Lincoln Park Capital Fund.

Where is PaxMedica headquartered?

PaxMedica is headquartered in Tarrytown, United States.

What does PaxMedica do?

PaxMedica is a biopharmaceutical company focused on developing innovative treatments for unmet needs in neurodevelopmental disorders.

What stage is PaxMedica at?

PaxMedica is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 20, 2023.

MLA

"PaxMedica — Funding & Investors." VCBacked, November 20, 2023, https://www.vcbacked.co/company/paxmedica. Accessed July 2, 2026.

APA

VCBacked. (2023). PaxMedica — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/paxmedica

Wikipedia (cite web)

{{cite web |title=PaxMedica — Funding & Investors |url=https://www.vcbacked.co/company/paxmedica |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 20, 2023.